Showing results (161-170 of 257) with videos related to

Sort By:
Pageof 26
Annals of Hematology|November 7, 2009
Amyloid in bone marrow smears of patients affected by multiple myelomaFara Petruzziello, Pio Zeppa, Lucio Catalano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2011
CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patientsIlaria Iacobucci, Anna Ferrari, Annalisa Lonetti, et al.
Plos One|August 1, 2012
IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemiaIlaria Iacobucci, Nunzio Iraci, Monica Messina, et al.
Haematologica|May 30, 2008
Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemiaFrancesco Lo-Coco, Antonio Cuneo, Fabrizio Pane, et al.
Haematologica|August 10, 2012
Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapySabrina Angelini, Simona Soverini, Gloria Ravegnini, et al.
Annals of Hematology|September 5, 2025
Impact of Dara-VTD induction therapy on stem cell mobilization outcomes in newly diagnosed multiple myeloma patients undergoing autologous stem cell transplantation: a multicenter studyRoberta Della Pepa, Salvatore Palmieri, Stefano Rocco, et al.
Anti-Cancer Drugs|October 22, 2019
An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemiaClaudio Cerchione, Giovanni Martinelli, Silvana Pedatella, et al.
Blood|October 14, 2009
Nilotinib for the frontline treatment of Ph(+) chronic myeloid leukemiaGianantonio Rosti, Francesca Palandri, Fausto Castagnetti, et al.
Blood|September 24, 2005
Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocolAntonella Vitale, Anna Guarini, Cristina Ariola, et al.
British Journal of Haematology|July 12, 2022
Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II studyMarco Picardi, Claudia Giordano, Novella Pugliese, et al.
Pageof 26